Select Medical Holdings Corp Files 8-K on Executive Changes
Ticker: SEM · Form: 8-K · Filed: Sep 2, 2025 · CIK: 1320414
Sentiment: neutral
Topics: executive-changes, compensation, corporate-governance
TL;DR
SELECT MEDICAL HOLDINGS CORP FILES 8-K: EXECUTIVE CHANGES AND COMPENSATION DETAILS REPORTED.
AI Summary
Select Medical Holdings Corporation filed an 8-K on September 1, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. The filing also includes Regulation FD disclosures and financial statements and exhibits.
Why It Matters
This filing provides insight into potential leadership changes and compensation structures within Select Medical Holdings Corporation, which could impact the company's strategic direction and financial performance.
Risk Assessment
Risk Level: low — The filing is a routine corporate disclosure and does not appear to contain any immediate negative financial or operational news.
Key Players & Entities
- SELECT MEDICAL HOLDINGS CORPORATION (company) — Registrant
- September 1, 2025 (date) — Date of earliest event reported
- 4714 Gettysburg Road (address) — Business and mailing address
- Mechanicsburg, PA 17055 (address) — Business and mailing address
FAQ
What specific executive positions were affected by the departures or appointments?
The filing indicates "Departure of Directors or Certain Officers" and "Appointment of Certain Officers" but does not specify the exact positions in the provided text.
Are there any details on the compensatory arrangements for the officers mentioned?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but the specific details of these arrangements are not included in the provided excerpt.
What is the significance of the Regulation FD Disclosure mentioned?
Regulation FD (Fair Disclosure) ensures that material information is broadly disseminated to the public, preventing selective disclosure to analysts or institutional investors.
What type of financial statements and exhibits are included in this filing?
The filing states "Financial Statements and Exhibits" are included, but the specific nature or content of these documents is not detailed in the provided text.
When was Select Medical Holdings Corporation incorporated and what is its EIN?
Select Medical Holdings Corporation was incorporated in Delaware and its EIN is 000000000, as per the filing.
Filing Stats: 903 words · 4 min read · ~3 pages · Grade level 10.8 · Accepted 2025-09-02 16:21:49
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share SEM New York Stock Exchange
- $618,000 — e salary since January 1, 2024 has been $618,000 and he has received grants of 100,000 s
Filing Documents
- tm2524778d1_8k.htm (8-K) — 32KB
- tm2524778d1_ex99-1.htm (EX-99.1) — 15KB
- tm2524778d1_ex99-1img001.jpg (GRAPHIC) — 21KB
- tm2524778d1_ex99-1img002.jpg (GRAPHIC) — 9KB
- 0001104659-25-086392.txt ( ) — 255KB
- sem-20250901.xsd (EX-101.SCH) — 3KB
- sem-20250901_lab.xml (EX-101.LAB) — 33KB
- sem-20250901_pre.xml (EX-101.PRE) — 22KB
- tm2524778d1_8k_htm.xml (XML) — 4KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On September 2, 2025, the Company issued a press release, among other things, announcing the appointment of Mr. Mullin as Chief Executive Officer. A copy of the press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference. The information in this Item 7.01 in this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Item9.01 Financial (d) Exhibits. Exhibit Number Description 99.1 Press Release, dated September 2, 2025, announcing the appointment of Mr. Mullin as Chief Executive Officer and other changes involving long-tenured leaders. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. SELECT MEDICAL HOLDINGS CORPORATION Date: September 2, 2025 By: /s/ John F. Duggan John F. Duggan Executive Vice President, General Counsel and Secretary